{"url": "https://techcrunch.com/2025/01/24/retro-biosciences-backed-by-sam-altman-is-raising-1-billion-to-extend-human-lifespan/", "title": "Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan", "authors": ["Charles Rollet", "Kyle Wiggers", "Theresa Loconsolo", "Anthony Ha", "Kirsten Korosec", "Maxwell Zeff", "Tim De Chant", ".Post-Authors-List__Authors --Font-Size Var", "Align-Items Center Display Flex Gap Var", ".Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Display Flex Flex-Shrink Margin Padding .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Li List-Style None Margin-Left Margin-Top Important .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Li First-Child Margin-Left .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs .Post-Authors-List__Author-Thumb Background-Color Var"], "publication_date": "2025-01-24T00:00:00", "text": "In Brief\n\nOpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.\n\nAltman previously provided Retro Biosciences\u2019 entire seed round of $180 million. Now, the startup is raising a $1 billion Series A that Altman is joining, the Financial Times reports.\n\nRetro Biosciences, which says it plans to launch trials for drugs targeting diseases like Alzheimer\u2019s, recently trained a model with OpenAI to turn regular cells into stem cells.\n\nCEO Joe Betts-LaCroix told the FT he wants to move fast by discovering and developing a drug \u201cin the 2020s.\u201d\n\nThe startup joins other major billionaire-backed longevity efforts, including Altos Labs, which launched with $3 billion in 2022 backed by Jeff Bezos, and Unity Biotechnology, supported by both Bezos and Peter Thiel."}